药物信息为Optiray 350 (Mallinckrodt Inc.): OVERDOSAGE
- WARNING
- DESCRIPTION
- CLINICAL PHARMACOLOGY
- CT SCANNING OF THE HEAD
- CT SCANNING OF THE BODY
- INDICATIONS AND USAGE
- CONTRAINDICATIONS
- ADVERSE REACTIONS
- OVERDOSAGE
- INDIVIDUAL INDICATIONS, USAGE AND PROCEDURAL INFORMATION GENERAL ANGIOGRAPHY
- COMPUTED TOMOGRAPHY
- INTRAVENOUS DIGITAL SUBTRACTION ANGIOGRAPHY
- HOW SUPPLIED
- RFID-Tagged Syringe Directions for Use
- 外部链接相关的Optiray 350 (Mallinckrodt Inc.)
The adverse effects of overdosage are life-threatening and affect mainly the pulmonary and cardiovascular system. Treatment of an overdosage is directed toward the support of all vital functions and prompt institution of symptomatic therapy.
Ioversol does not bind to plasma or serum protein and is, therefore, dialyzable.
The intravenous LD50 values (gI/kg) for ioversol in animals were: 17 (mice), and 15 (rats).
- Drug Information Provided by National Library of Medicine (NLM).
